Nasdaq · Healthcare
T3 Defense Inc. (DFNS)
As-reported financials and recent SEC filings for T3 Defense Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
—
Net income
$78.5M
Net margin
—
Diluted EPS
$7.96
ROE
-504.2%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | — | $5.9M | $21.3M | — | $21.5M |
| Gross profit | — | $998,516 | $-343,141 | — | $-661,396 |
| Operating income | $-32.6M | $-7.1M | $-14.7M | $-1.2M | $-11.1M |
| Net income | $78.5M | $-8.5M | $-17.4M | $-967,614 | $-11.8M |
| Diluted EPS | $7.96 | $-0.99 | $-2.77 | $-0.17 | $-1.94 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
424B32026-07-01
View on EDGAR →EFFECT2026-06-30
View on EDGAR →8-K2026-06-29
View on EDGAR →S-1/A2026-06-25
View on EDGAR →8-K2026-06-18
View on EDGAR →DEFA14A2026-06-17
View on EDGAR →8-K2026-06-15
View on EDGAR →32026-06-11
View on EDGAR →Largest Healthcare peers
Go deeper on DFNS
Search T3 Defense Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.